Donoghue Forlines’s Microchip Technology MCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,228
Closed -$1.7M 195
2024
Q3
$1.7M Buy
21,228
+9,788
+86% +$808K 0.49% 43
2024
Q2
$1.05M Sell
11,440
-1,494
-12% -$137K 0.3% 86
2024
Q1
$1.16M Buy
12,934
+1,521
+13% +$131K 0.33% 83
2023
Q4
$1.03M Sell
11,413
-2,296
-17% -$187K 0.32% 86
2023
Q3
$1.07M Sell
13,709
-13,461
-50% -$1.13M 0.38% 87
2023
Q2
$2.43M Buy
27,170
+2,024
+8% +$160K 0.76% 18
2023
Q1
$2.11M Sell
25,146
-8,375
-25% -$668K 0.76% 18
2022
Q4
$2.35M Buy
33,521
+10,434
+45% +$719K 0.83% 19
2022
Q3
$1.41M Buy
23,087
+2,254
+11% +$148K 0.51% 18
2022
Q2
$1.21M Sell
20,833
-10,902
-34% -$722K 0.32% 65
2022
Q1
$2.38M Buy
31,735
+20,383
+180% +$1.53M 0.52% 33
2021
Q4
$988K Sell
11,352
-16,606
-59% -$1.34M 0.17% 138
2021
Q3
$2.15M Sell
27,958
-352
-1% -$26.4K 0.42% 50
2021
Q2
$2.12M Buy
28,310
+15,496
+121% +$1.18M 0.4% 56
2021
Q1
$994K Sell
12,814
-1,708
-12% -$127K 0.19% 131
2020
Q4
$1M Buy
+14,522
New +$904K 0.19% 152

Other funds holding MCHP

Donoghue Forlines's MCHP Position: Q4 2024 in Review

Donoghue Forlines sold out of Microchip Technology (MCHP) in Q4 2024, closing a stake of 21,228 shares — an estimated $1.7M sold.

Donoghue Forlines first reported a position in MCHP in Q4 2020 and held it in 16 quarters. The position peaked at $2.43M in Q2 2023. 1,127 funds tracked by Wall St. Rank hold MCHP as of Q4 2024.

  • Donoghue Forlines reported no remaining Microchip Technology position as of Q4 2024 after selling out during the quarter.
  • Donoghue Forlines sold 21,228 Microchip Technology shares in Q4 2024, an estimated $1.7M.
  • Donoghue Forlines first reported a position in Microchip Technology in Q4 2020 and held it in 16 quarters.
  • Donoghue Forlines's Microchip Technology position peaked at $2.43M in Q2 2023.
  • 1,127 funds tracked by Wall St. Rank held Microchip Technology as of Q4 2024.

Based on Donoghue Forlines's 13F filing for Q4 2024, filed 17 Jan 2025.